InterOcean Capital Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

InterOcean Capital Group’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$1.24M	Sell	13,116 -50,815	-79%	-$4.72M	0.03%	183
2023 Q4	$5.71M	Sell	63,931 -236	-0.4%	-$17.5K	0.15%	95
2023 Q3	$4.69M	Sell	64,167 -208,379	-76%	-$16.6M	0.14%	96
2023 Q2	$22.7M	Sell	272,546 -10,146	-4%	-$848K	0.71%	38
2023 Q1	$21.5M	Buy	282,692 +21,171	+8%	+$1.76M	0.73%	39
2022 Q4	$21.7M	Sell	261,521 -5,476	-2%	-$443K	0.79%	38
2022 Q3	$21.2M	Buy	266,997 +10,229	+4%	+$862K	0.87%	37
2022 Q2	$19.1M	Buy	256,768 +25,345	+11%	+$1.9M	0.78%	41
2022 Q1	$20.8M	Buy	231,423 +15,421	+7%	+$1.42M	0.89%	38
2021 Q4	$24.2M	Buy	216,002 +23,860	+12%	+$2.88M	1.05%	32
2021 Q3	$24.2M	Buy	192,142 +79,612	+71%	+$10.3M	1.21%	29
2021 Q2	$15.2M	Buy	112,530 +106,670	+1,820%	+$14M	0.78%	37
2021 Q1	$795K	Buy	5,860 +1,180	+25%	+$177K	0.04%	125
2020 Q4	$659K	Buy	+4,680	New	+$599K	0.04%	117

Other funds holding XBI

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

InterOcean Capital Group's XBI Position: Q1 2024 in Review

InterOcean Capital Group reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 79% in Q1 2024, selling an estimated $4.72M and leaving 13,116 shares worth $1.24M. The position accounts for 0.03% of the portfolio, ranked #183.

InterOcean Capital Group first reported a position in XBI in Q4 2020 and has held it in 14 quarters since. The position peaked at $24.2M in Q4 2021. 781 funds tracked by Wall St. Rank hold XBI as of Q1 2024.

InterOcean Capital Group held 13,116 shares of State Street SPDR S&P Biotech ETF worth $1.24M as of Q1 2024.
InterOcean Capital Group sold 50,815 State Street SPDR S&P Biotech ETF shares in Q1 2024, an estimated $4.72M.
State Street SPDR S&P Biotech ETF made up 0.03% of InterOcean Capital Group's portfolio in Q1 2024, its #183 holding.
InterOcean Capital Group first reported a position in State Street SPDR S&P Biotech ETF in Q4 2020 and has held it in 14 quarters since.
InterOcean Capital Group's State Street SPDR S&P Biotech ETF position peaked at $24.2M in Q4 2021.
781 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2024.

Based on InterOcean Capital Group's 13F filing for Q1 2024, filed 13 May 2024.